Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Biofrontera Inc’s stock clocked out at $0.79, down -0.19% from its previous closing price of $0.79. In other words, the price has decreased by -$0.19 from its previous closing price. On the day, 71332.0 shares were traded. BFRI stock price reached its highest trading level at $0.8005 during the session, while it also had its lowest trading level at $0.7641.
Ratios:
To gain a deeper understanding of BFRI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 1.15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BFRI now has a Market Capitalization of 9184703 and an Enterprise Value of 10662703. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25. Its current Enterprise Value per Revenue stands at 0.287 whereas that against EBITDA is -0.609.
Stock Price History:
The Beta on a monthly basis for BFRI is 0.61, which has changed by -0.122222245 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, BFRI has reached a high of $1.87, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -19.11%, while the 200-Day Moving Average is calculated to be -9.16%.
Shares Statistics:
It appears that BFRI traded 129.78K shares on average per day over the past three months and 138390 shares per day over the past ten days. A total of 11.65M shares are outstanding, with a floating share count of 9.79M. Insiders hold about 15.94% of the company’s shares, while institutions hold 21.71% stake in the company. Shares short for BFRI as of 1763078400 were 32743 with a Short Ratio of 0.25, compared to 1760486400 on 66545. Therefore, it implies a Short% of Shares Outstanding of 32743 and a Short% of Float of 0.29.
Earnings Estimates
As of right now, 1.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.18 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$1.51 and -$1.51 for the fiscal current year, implying an average EPS of -$1.51. EPS for the following year is -$0.23, with 1.0 analysts recommending between -$0.23 and -$0.23.
Revenue Estimates
In. The current quarter, 2 analysts expect revenue to total $15.54M. It ranges from a high estimate of $16.07M to a low estimate of $15M. As of. The current estimate, Biofrontera Inc’s year-ago sales were $12.56MFor the next quarter, 2 analysts are estimating revenue of $9.1M. There is a high estimate of $9.1M for the next quarter, whereas the lowest estimate is $9.1M.
A total of 2 analysts have provided revenue estimates for BFRI’s current fiscal year. The highest revenue estimate was $40.68M, while the lowest revenue estimate was $39.6M, resulting in an average revenue estimate of $40.14M. In the same quarter a year ago, actual revenue was $37.32MBased on 2 analysts’ estimates, the company’s revenue will be $44.54M in the next fiscal year. The high estimate is $44.98M and the low estimate is $44.1M.
